Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Blood. 2011 May 26;117(21):5607-11. doi: 10.1182/blood-2010-11-322149. Epub 2011 Mar 24.
Mutations in the essential telomerase components hTERT and hTR cause dyskeratosis congenita, a bone marrow failure syndrome characterized by mucocutaneous features. Some (~ 3%) sporadic aplastic anemia (AA) and idiopathic pulmonary fibrosis cases also carry mutations in hTERT and hTR. Even though it can affect clinical outcome, because the mutation frequency is rare, genetic testing is not standard. We examined whether the cooccurrence of bone marrow failure and pulmonary fibrosis in the same individual or family enriches for the presence of a telomerase mutation. Ten consecutive individuals with a total of 36 family members who fulfilled these criteria carried a germline mutant telomerase gene (100%). The mean age of onset for individuals with AA was significantly younger than that for those with pulmonary fibrosis (14 vs 51; P < .0001). Families displayed autosomal dominant inheritance and there was an evolving pattern of genetic anticipation, with the older generation primarily affected by pulmonary fibrosis and successive generations by bone marrow failure. The cooccurrence of AA and pulmonary fibrosis in a single patient or family is highly predictive for the presence of a germline telomerase defect. This diagnosis affects the choice of bone marrow transplantation preparative regimen and can prevent morbidity.
端粒酶成分 hTERT 和 hTR 的突变会导致先天性角化不良,这是一种骨髓衰竭综合征,其特征为黏膜皮肤表现。一些(约 3%)散发性再生障碍性贫血(AA)和特发性肺纤维化病例也存在 hTERT 和 hTR 的突变。尽管它可能影响临床结果,但由于突变频率较低,因此遗传检测不是标准检测。我们研究了同一患者或家族中骨髓衰竭和肺纤维化的同时发生是否会增加端粒酶突变的存在。连续 10 例符合这些标准的个体共有 36 名家庭成员,携带胚系突变端粒酶基因(100%)。AA 患者的发病年龄明显低于肺纤维化患者(14 岁 vs 51 岁;P <.0001)。家族呈现常染色体显性遗传,存在遗传预期的演变模式,即老一辈主要受肺纤维化影响,而后续几代则受骨髓衰竭影响。单个患者或家族中 AA 和肺纤维化的同时发生高度提示存在胚系端粒酶缺陷。这种诊断会影响骨髓移植预处理方案的选择,并可预防发病。